Associated Papers
ABCB1, ABCG2, ABCC1, ABCC2, and ABCC3 drug transporter polymorphisms and their impact on drug bioavailability: what is our current understanding?
Bruckmueller H et al.
Expert Opinion on Drug Metabolism & Toxicology, 2021
Selected ABCB1, ABCB4 and ABCC2 polymorphisms do not enhance the risk of drug-induced hepatotoxicity in a Spanish cohort.
Ulzurrun E et al.
Plos One, 2014
Impact of ABCC2 polymorphisms on high-dose methotrexate pharmacokinetics in patients with lymphoid malignancy.
Simon N et al.
The Pharmacogenomics Journal, 2013
Effect of ABCC2 (MRP2) transport function on erythromycin metabolism.
Franke RM et al.
Clinical Pharmacology and Therapeutics, 2011
Select a paper to view details